IM‐B is a herbal formula comprising extracts derived from four medicinal herbs previously reported to exhibit antioxidant and anti‐inflammatory properties. In this study, the bioactive compounds of IM‐B extract, as well as its antioxidant and anti‐inflammatory properties, were explored. Chemical compounds in IM‐B extract were identified through phytochemical analysis using LC–ESI–QTOF–MS/MS. Fifteen compounds comprising naringenin 5‐methyl ether, alpinetin, pinocembrin, 2′,4′,6′‐trihydroxydihydrochalcone, demethoxycurcumin, curcumin, alpinetin methyl ether, caffeic acid, myrcene, bisdemethoxycurcumin, geraniol, pinostrobin, pinostrobin chalcone, cannabidiol, and astaxanthin were analyzed. Based on the total phenolic (106.20 ± 3.11 mg GAE/g extract) and flavonoid (94.65 ± 2.65 mg QE/g extract) contents of the IM‐B extract, we consider it a good source of these secondary metabolites. Its antioxidant activities were 4.03 ± 0.63 μg/mL, 9.11 ± 0.57 μg/mL, and 126.84 ± 0.30 mg FeSO 4 /g extract based on 2,2′‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulfonic acid) (ABTS), 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH), and ferric reducing antioxidant power (FRAP) assays, respectively. Analyses of the association of IM‐B extract with nitric oxide (NO), prostaglandin E2, and cytokines (tumor necrosis factor‐ α [TNF‐ α ] and interleukin‐6 [IL‐6]) revealed that IM‐B extract significantly inhibits the LPS‐stimulated proinflammatory responses in RAW 264.7 macrophage cells. These findings support the potential effectiveness of IM‐B as an herbal supplement in health promotion.